Search results
Cara Therapeutics (NASDAQ:CARA shareholders incur further losses as stock declines 8.8% this week,...
Simply Wall St. via Yahoo Finance· 1 year agoFor many investors, the main point of stock picking is to generate higher returns than the overall...
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoCara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript March 4, 2024 Cara...
CARA's Late-Stage Skin Disease Study Fails, Stock Plummets 49%
Zacks via Yahoo Finance· 5 months agoCARA discontinues the clinical program of oral difelikefalin for pruritus associated with atopic...
Cara Therapeutics, Inc.'s (NASDAQ:CARA) P/S Is On The Mark
Simply Wall St. via Yahoo Finance· 1 year agoYou may think that with a price-to-sales (or "P/S") ratio of 4.4x Cara Therapeutics, Inc....
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 10 months agoCara (CARA) delivered earnings and revenue surprises of -3.57% and 6.79%, respectively, for the...
Cara Therapeutics (CARA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zacks via Yahoo Finance· 2 years agoCara (CARA) possesses the right combination of the two key ingredients for a likely earnings beat in...
Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 65%
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Institutions' substantial holdings in Cara Therapeutics implies that they have...
Cara Therapeutics, Inc. (NASDAQ:CARA) Analysts Just Cut Their EPS Forecasts Substantially
Simply Wall St. via Yahoo Finance· 1 year agoMarket forces rained on the parade of Cara Therapeutics, Inc. (NASDAQ:CARA) shareholders today, when...
News Flash: Analysts Just Made A Substantial Upgrade To Their Cara Therapeutics, Inc. (NASDAQ:CARA)...
Simply Wall St. via Yahoo Finance· 7 months agoCara Therapeutics, Inc. (NASDAQ:CARA) shareholders will have a reason to smile today, with the...
The past five years for Cara Therapeutics (NASDAQ:CARA) investors has not been profitable
Simply Wall St. via Yahoo Finance· 11 months agoSome stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss....